Dianthus Therapeutics
DNTH
DNTH
140 hedge funds and large institutions have $1.84B invested in Dianthus Therapeutics in 2025 Q3 according to their latest regulatory filings, with 51 funds opening new positions, 43 increasing their positions, 34 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
26% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 34
23.88% more ownership
Funds ownership: 121.6% → 145.48% (+24%)
9% more call options, than puts
Call options by funds: $15.6M | Put options by funds: $14.3M
Holders
140
Holding in Top 10
11
Calls
$15.6M
Puts
$14.3M
Top Buyers
| 1 | +$98.5M | |
| 2 | +$57.5M | |
| 3 | +$56.1M | |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
+$32.9M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$29.4M |
Top Sellers
| 1 | -$79.5M | |
| 2 | -$45.9M | |
| 3 | -$41.6M | |
| 4 |
5VM
5AM Venture Management
San Francisco,
California
|
-$24.4M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$14.1M |
